Michael Johns

1.1k total citations
49 papers, 901 citations indexed

About

Michael Johns is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael Johns has authored 49 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Surgery and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael Johns's work include Atherosclerosis and Cardiovascular Diseases (8 papers), Pancreatic function and diabetes (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Michael Johns is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (8 papers), Pancreatic function and diabetes (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Michael Johns collaborates with scholars based in United States, United Kingdom and Switzerland. Michael Johns's co-authors include Dorian O. Haskard, Justin C. Mason, Joseph J. Boyle, Aivi T. Nguyen, Dominik J. Schaer, Laurence Gamé, Paul C. Evans, Andrew J.T. George, Nicola Ambrose and Mary A. Ritter and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Circulation Research.

In The Last Decade

Michael Johns

49 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Johns United States 17 364 334 129 122 110 49 901
Zihua Zhou China 18 315 0.9× 417 1.2× 107 0.8× 224 1.8× 89 0.8× 64 1.1k
Randolph Hutter United States 18 374 1.0× 320 1.0× 146 1.1× 313 2.6× 103 0.9× 31 1.2k
Pontus Dunér Sweden 20 489 1.3× 552 1.7× 184 1.4× 200 1.6× 65 0.6× 44 1.2k
Micah L. Burch Australia 21 683 1.9× 159 0.5× 165 1.3× 135 1.1× 97 0.9× 28 1.2k
Antonija Jurak Begonja Croatia 16 305 0.8× 231 0.7× 81 0.6× 93 0.8× 105 1.0× 38 1.2k
Jack Leslie United Kingdom 17 396 1.1× 174 0.5× 260 2.0× 93 0.8× 184 1.7× 34 1.1k
Nikolina Papac-Miličević Austria 13 326 0.9× 599 1.8× 271 2.1× 134 1.1× 58 0.5× 17 1.1k
Kunimasa Yan Japan 23 561 1.5× 151 0.5× 79 0.6× 167 1.4× 83 0.8× 52 1.4k
Kwang Seok Kim South Korea 16 497 1.4× 230 0.7× 76 0.6× 62 0.5× 143 1.3× 41 990
Nobuhide Hayashi Japan 12 423 1.2× 147 0.4× 130 1.0× 81 0.7× 127 1.2× 42 1.0k

Countries citing papers authored by Michael Johns

Since Specialization
Citations

This map shows the geographic impact of Michael Johns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Johns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Johns more than expected).

Fields of papers citing papers by Michael Johns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Johns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Johns. The network helps show where Michael Johns may publish in the future.

Co-authorship network of co-authors of Michael Johns

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Johns. A scholar is included among the top collaborators of Michael Johns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Johns. Michael Johns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Johns, Michael, et al.. (2022). A cost analysis of sorafenib for desmoid tumors. Journal of Oncology Pharmacy Practice. 29(3). 663–668. 2 indexed citations
3.
Kim, Sun Hee, Sangdon Han, Elizabeth Rico-Bautista, et al.. (2022). Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism. Bioorganic & Medicinal Chemistry Letters. 71. 128807–128807. 2 indexed citations
4.
Johns, Michael & Nicholas J. Petrelli. (2021). Microbiome and colorectal cancer: A review of the past, present, and future. Surgical Oncology. 37. 101560–101560. 7 indexed citations
5.
Fowler, Melissa, Ana Karin Kusnetzow, Sangdon Han, et al.. (2021). Effects of CRN04894, a Nonpeptide Orally Bioavailable ACTH Antagonist, on Corticosterone in Rodent Models of ACTH Excess. Journal of the Endocrine Society. 5(Supplement_1). A167–A167. 4 indexed citations
6.
Kusnetzow, Ana Karin, Melissa Fowler, Greg J. Reinhart, et al.. (2019). SAT-364 Nonpeptide Orally-Bioavailable ACTH Antagonists: Suppression of ACTH-Induced Corticosterone Secretion and Adrenal Hypertrophy in Rats. Journal of the Endocrine Society. 3(Supplement_1). 4 indexed citations
7.
8.
9.
Ambrose, Nicola, Josefin Ahnström, Miles Stanford, et al.. (2016). A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet’s Syndrome. Scientific Reports. 6(1). 38104–38104. 19 indexed citations
10.
Johns, Michael, William L. Neumann, Timothy McPherson, et al.. (2015). SR-135, a peroxynitrite decomposing catalyst, enhances β-cell function and survival in B6D2F1 mice fed a high fat diet. Archives of Biochemistry and Biophysics. 577-578. 49–59. 7 indexed citations
11.
Chang, Wei, et al.. (2013). The development of a normalization method for comparing nerve regeneration effectiveness among different graft types. Journal of the Peripheral Nervous System. 18(4). 297–305. 3 indexed citations
12.
Chang, Shang‐Hung, Michael Johns, Joseph J. Boyle, et al.. (2012). Model IgG Monoclonal Autoantibody–Anti-Idiotype Pair for Dissecting the Humoral Immune Response to Oxidized Low Density Lipoprotein. Hybridoma. 31(2). 87–98. 9 indexed citations
13.
Boyle, Joseph J., Aivi T. Nguyen, Paul C. Evans, et al.. (2012). Solid-Phase Immunoglobulins IgG and IgM Activate Macrophages with Solid-Phase IgM Acting via a Novel Scavenger Receptor A Pathway. American Journal Of Pathology. 181(1). 347–361. 13 indexed citations
14.
Chen, Chen, Fábio C. Tucci, Wanlong Jiang, et al.. (2008). Pharmacological and pharmacokinetic characterization of 2-piperazine-α-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists. Bioorganic & Medicinal Chemistry. 16(10). 5606–5618. 18 indexed citations
15.
Dyck, Brian, Mingzhu Zhang, Beth A. Fleck, et al.. (2008). Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(11). 3230–3235. 12 indexed citations
16.
Kinderlerer, Anne, Faisal Ali, Michael Johns, et al.. (2008). KLF2-dependent, Shear Stress-induced Expression of CD59. Journal of Biological Chemistry. 283(21). 14636–14644. 42 indexed citations
17.
Dyck, Brian, Margaret Bradbury, Jenny Wen, et al.. (2008). Characterization of Thien-2-yl 1S,2R-Milnacipran Analogues as Potent Norepinephrine/Serotonin Transporter Inhibitors for the Treatment of Neuropathic Pain. Journal of Medicinal Chemistry. 51(22). 7265–7272. 9 indexed citations
18.
Jiang, Wanlong, Fábio C. Tucci, Joe A. Tran, et al.. (2007). Pyrrolidinones as potent functional antagonists of the human melanocortin-4 receptor. Bioorganic & Medicinal Chemistry Letters. 17(20). 5610–5613. 16 indexed citations
19.
Imami, Nesrina, Paul Brookes, Giovanna Lombardi, et al.. (1998). ASSOCIATION BETWEEN INTERLEUKIN-4-PRODUCING T LYMPHOCYTE FREQUENCIES AND REDUCED RISK OF GRAFT-VERSUS-HOST DISEASE1. Transplantation. 65(7). 979–988. 19 indexed citations
20.
Johns, Michael, et al.. (1989). The effect of intravenous nutrition on muscle mass and exercise capacity in perioperative patients. The American Journal of Surgery. 158(1). 63–67. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zihua Zhou Breakdown of academic impact, for papers by Randolph Hutter Breakdown of academic impact, for papers by Pontus Dunér Breakdown of academic impact, for papers by Micah L. Burch Breakdown of academic impact, for papers by Antonija Jurak Begonja Breakdown of academic impact, for papers by Jack Leslie Breakdown of academic impact, for papers by Nikolina Papac-Miličević Breakdown of academic impact, for papers by Kunimasa Yan Breakdown of academic impact, for papers by Kwang Seok Kim Breakdown of academic impact, for papers by Nobuhide Hayashi
Rankless by CCL
2026